van Rijswijk, A. http://orcid.org/0000-0002-8086-3265
van Olst, N.
Meijnikman, A. S.
Acherman, Y. I. Z.
Bruin, S. C.
van de Laar, A. W.
van Olden, C. C.
Aydin, O.
Borger, H.
Beuers, U. H. W.
Herrema, H.
Verheij, J.
Apers, J. A.
Bäckhed, F.
Gerdes, V. E. A.
Nieuwdorp, M.
de Brauw, L. M.
Article History
Received: 4 May 2022
Accepted: 16 September 2022
First Online: 22 October 2022
Declarations
:
: Ethical approval has been granted by the “Medisch Ethische Toetsingscommissie van het Slotervaartziekenhuis en Reade,” Amsterdam, the Netherlands, belonging to MC Slotervaart and by the “Medisch Ethische Toetsingscommissie AMC,” Amsterdam, the Netherlands, belonging to Amsterdam UMC. Patients will be asked for written informed consent to participate by the surgeon and to store study materials.
: Not applicable.
: F.B. is a founder and in the Scientific Advisory Board of MetaboGen AB, Sweden. M.N. is the founder and in the Scientific Advisory Board of Caelus Pharmaceuticals, the Netherlands. None of these are directly relevant to the current paper. The remaining authors declare that they have no conflict of interest.